ICM
CHRA

Invenomic Capital Management’s Charah Solutions, Inc Common Stock CHRA Stock Holding History

Invenomic Capital Management’s Portfolio CHRA Stock Details CHRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,384
Closed -$349K – 182
2020
Q3 		$349K Buy
11,384
+3,938
+53% +$111K 0.19% 109
2020
Q2 		$237K Buy
+7,446
New +$129K 0.18% 128

Other funds holding CHRA

PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invenomic Capital Management's CHRA Position: Q4 2020 in Review

Invenomic Capital Management sold out of Charah Solutions, Inc Common Stock (CHRA) in Q4 2020, closing a stake of 11,384 shares — an estimated $349K sold.

Invenomic Capital Management first reported a position in CHRA in Q2 2020 and held it in 2 quarters. The position peaked at $349K in Q3 2020. 18 funds tracked by Wall St. Rank hold CHRA as of Q4 2020.

  • Invenomic Capital Management reported no remaining Charah Solutions, Inc Common Stock position as of Q4 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 11,384 Charah Solutions, Inc Common Stock shares in Q4 2020, an estimated $349K.
  • Invenomic Capital Management first reported a position in Charah Solutions, Inc Common Stock in Q2 2020 and held it in 2 quarters.
  • Invenomic Capital Management's Charah Solutions, Inc Common Stock position peaked at $349K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Charah Solutions, Inc Common Stock as of Q4 2020.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.